23 related articles for article (PubMed ID: 8073224)
1. The molecular interaction of 4'-iodo-4'-deoxydoxorubicin with Leu-55Pro transthyretin 'amyloid-like' oligomer leading to disaggregation.
Sebastião MP; Merlini G; Saraiva MJ; Damas AM
Biochem J; 2000 Oct; 351(Pt 1):273-9. PubMed ID: 10998371
[TBL] [Abstract][Full Text] [Related]
2. Long-lasting effect of dexrazoxane against anthracycline cardiotoxicity in rats.
Della Torre P; Podesta A; Pinciroli G; Iatropoulos MJ; Mazué G
Toxicol Pathol; 1996; 24(4):398-402. PubMed ID: 8864181
[TBL] [Abstract][Full Text] [Related]
3. Reduction of the cardiotoxicity of doxorubicin in rabbits and dogs by encapsulation in long-circulating, pegylated liposomes.
Working PK; Newman MS; Sullivan T; Yarrington J
J Pharmacol Exp Ther; 1999 May; 289(2):1128-33. PubMed ID: 10215696
[TBL] [Abstract][Full Text] [Related]
4. The rat model in the comparative evaluation of anthracyclines cardiotoxicity.
Lanza E; Rozza A; Favalli L; Monti E; Poggi P; Villani F
Tumori; 1989 Dec; 75(6):533-6. PubMed ID: 2617699
[TBL] [Abstract][Full Text] [Related]
5. Dissociation between in vitro cytotoxicity and in vivo cardiotoxicity of two new anthracyclines: 3'-deamino-3'-(2-methoxy-4-morpholinyl)doxorubicin and 4'-deoxy-4'-iodo-doxorubicin.
Pinna A; Agen C; Di Paolo A; Innocenti F; Nardini D; Danesi R; Del Tacca M
J Environ Pathol Toxicol Oncol; 1994; 13(1):25-31. PubMed ID: 7823290
[TBL] [Abstract][Full Text] [Related]
6. Comparison of doxorubicin- and MEN 10755-induced long-term progressive cardiotoxicity in the rat.
Cirillo R; Sacco G; Venturella S; Brightwell J; Giachetti A; Manzini S
J Cardiovasc Pharmacol; 2000 Jan; 35(1):100-8. PubMed ID: 10630739
[TBL] [Abstract][Full Text] [Related]
7. Preclinical assessment of anthracycline cardiotoxicity in laboratory animals: predictiveness and pitfalls.
Robert J
Cell Biol Toxicol; 2007 Jan; 23(1):27-37. PubMed ID: 17041747
[TBL] [Abstract][Full Text] [Related]
8. Long-term and short-term models for studying anthracycline cardiotoxicity and protectors.
Robert J
Cardiovasc Toxicol; 2007; 7(2):135-9. PubMed ID: 17652818
[TBL] [Abstract][Full Text] [Related]
9. Role of mtDNA lesions in anthracycline cardiotoxicity.
Lebrecht D; Walker UA
Cardiovasc Toxicol; 2007; 7(2):108-13. PubMed ID: 17652814
[TBL] [Abstract][Full Text] [Related]
10. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses.
Olson RD; Mushlin PS
FASEB J; 1990 Oct; 4(13):3076-86. PubMed ID: 2210154
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of 4'-iodo-4'-deoxydoxorubicin-induced cardiotoxicity in two experimental rat models.
Podestà A; Della Torre P; Pinciroli G; Iatropoulos MJ; Brughera M; Mazué G
Toxicol Pathol; 1994; 22(1):68-71. PubMed ID: 8073224
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
